North Star Investment Management Corp. Acquires New Holdings in Electromed, Inc. $ELMD

North Star Investment Management Corp. bought a new stake in Electromed, Inc. (NYSE:ELMD) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 34,000 shares of the company’s stock, valued at approximately $796,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Raymond James Financial Inc. increased its holdings in Electromed by 0.9% in the 3rd quarter. Raymond James Financial Inc. now owns 58,838 shares of the company’s stock worth $1,444,000 after purchasing an additional 507 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Electromed by 0.4% during the third quarter. Dimensional Fund Advisors LP now owns 190,103 shares of the company’s stock worth $4,667,000 after purchasing an additional 696 shares during the last quarter. American Century Companies Inc. grew its holdings in shares of Electromed by 3.1% during the second quarter. American Century Companies Inc. now owns 32,031 shares of the company’s stock worth $704,000 after purchasing an additional 969 shares during the last quarter. Kestra Advisory Services LLC bought a new stake in shares of Electromed during the fourth quarter worth about $29,000. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Electromed in the fourth quarter valued at approximately $43,000. Institutional investors own 40.82% of the company’s stock.

Insider Activity at Electromed

In other Electromed news, CEO James L. Cunniff sold 9,700 shares of the firm’s stock in a transaction that occurred on Monday, June 8th. The shares were sold at an average price of $36.50, for a total transaction of $354,050.00. Following the completion of the transaction, the chief executive officer owned 147,751 shares in the company, valued at approximately $5,392,911.50. This trade represents a 6.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kathleen Skarvan sold 40,000 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $35.48, for a total transaction of $1,419,200.00. Following the transaction, the director owned 35,622 shares of the company’s stock, valued at approximately $1,263,868.56. The trade was a 52.89% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 61,501 shares of company stock worth $2,202,216 over the last ninety days. Insiders own 10.50% of the company’s stock.

Electromed Trading Up 1.9%

Shares of ELMD stock opened at $42.23 on Tuesday. Electromed, Inc. has a 1-year low of $17.73 and a 1-year high of $43.05. The stock has a market cap of $349.66 million, a price-to-earnings ratio of 56.31 and a beta of 0.53. The stock has a 50-day moving average of $34.05 and a 200-day moving average of $29.08.

Analyst Ratings Changes

ELMD has been the subject of a number of research reports. B. Riley Financial raised their price objective on shares of Electromed from $38.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Zacks Research upgraded shares of Electromed from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. One investment analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company’s stock. According to MarketBeat, Electromed has a consensus rating of “Buy” and an average price target of $37.50.

Electromed Company Profile

Electromed Inc (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients.

The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components.